Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Boe Sandahl, Sørensen"'
Autor:
Jesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, Adam Andrzej Luczak, Ninna Aggerholm-Pedersen, Nicolai Juul Birkbak, Trine Heide Øllegaard, Martin Roelsgaard Jakobsen
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3342
Pedersen, J G, Sokac, M, Sørensen, B S, Luczak, A A, Aggerholm-Pedersen, N, Birkbak, N J, Øllegaard, T H & Jakobsen, M R 2022, ' Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma ', Cancers, vol. 14, no. 14, 3342 . https://doi.org/10.3390/cancers14143342
Pedersen, J G, Sokac, M, Sørensen, B S, Luczak, A A, Aggerholm-Pedersen, N, Birkbak, N J, Øllegaard, T H & Jakobsen, M R 2022, ' Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma ', Cancers, vol. 14, no. 14, 3342 . https://doi.org/10.3390/cancers14143342
Background: Checkpoint inhibitors have revolutionized the treatment of metastatic melanoma, yielding long-term survival in a considerable proportion of the patients. Yet, 40–60% of patients do not achieve a long-term benefit from such therapy, emph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f85e9a6b6f8cf62b8163dfc477b80d1
Autor:
Inger Johanne Zwicky Eide, Simone Stensgaard, Åslaug Helland, Simon Ekman, Anders Mellemgaard, Karin Holmskov Hansen, Saulius Cicenas, Jussi Koivunen, Bjørn Henning Grønberg, Boe Sandahl Sørensen, Odd Terje Brustugun
Publikováno v:
Eide, I J Z, Stensgaard, S, Helland, Å, Ekman, S, Mellemgaard, A, Hansen, K H, Cicenas, S, Koivunen, J, Grønberg, B H, Sørensen, B S & Brustugun, O T 2022, ' Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations : a post-hoc subgroup analysis with pooled data from two phase II clinical trials ', Translational Lung Cancer Research, vol. 11, no. 6, pp. 953-963 . https://doi.org/10.21037/tlcr-21-995
Translational Lung Cancer Research (TLCR)
Translational Lung Cancer Research (TLCR)
Background: Osimertinib is standard of care for EGFR-mutated non-small cell lung cancer (NSCLC) patients. The efficacy of the drug in patients with mutations other than the common deletion in exon 19 and L858R in exon 21 is largely unknown. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf92d28602e537f5a1f22275cc40a2cd
https://pure.au.dk/portal/da/publications/osimertinib-in-nonsmall-cell-lung-cancer-with-uncommon-egfrmutations(f24c391e-f99d-4b57-abe6-9af9f1018ea3).html
https://pure.au.dk/portal/da/publications/osimertinib-in-nonsmall-cell-lung-cancer-with-uncommon-egfrmutations(f24c391e-f99d-4b57-abe6-9af9f1018ea3).html
Autor:
Inger Johanne Zwicky, Eide, Simone, Stensgaard, Åslaug, Helland, Simon, Ekman, Anders, Mellemgaard, Karin Holmskov, Hansen, Saulius, Cicenas, Jussi, Koivunen, Bjørn Henning, Grønberg, Boe Sandahl, Sørensen, Odd Terje, Brustugun
Publikováno v:
Translational lung cancer research. 11(6)
Osimertinib is standard of care forWe identified patients with uncommonOf 299 enrolled patients in the two trials, 21 patients with uncommon mutations were identified; 12 patients had a single mutation (G719X or L861Q), one patient had L861Q and an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbd0f24101628cf538fd982611fac652
https://pubmed.ncbi.nlm.nih.gov/35958324
https://pubmed.ncbi.nlm.nih.gov/35958324
Publikováno v:
Thune Mouritzen, M, Carus, A, Meldgaard, P, Sørensen, B S & Hager, H 2018, ' Nye biomarkører for behandling med immun checkpoint inhibitorer ved avanceret ikke-småcellet lungekræft ', Dansk Selskab for Klinisk Onkologi Årsmøde 2018, Nyborg, Danmark, 12/04/2018-14/04/2018 .
Aalborg University
Thune Mouritzen, M, Hager, H, Sørensen, B S, Meldgaard, P & Carus, A 2018, Nye biomarkører for behandling med immun checkpoint inhibitorer ved avanceret ikke-småcellet lungekræft . i Danske Kræftforskningsdage : Abstract Book ., #99, s. 107, Danske Kræftforskningsdage 2018, Odense, Danmark, 30/08/2018 .
Aalborg University
Thune Mouritzen, M, Hager, H, Sørensen, B S, Meldgaard, P & Carus, A 2018, Nye biomarkører for behandling med immun checkpoint inhibitorer ved avanceret ikke-småcellet lungekræft . i Danske Kræftforskningsdage : Abstract Book ., #99, s. 107, Danske Kræftforskningsdage 2018, Odense, Danmark, 30/08/2018 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::010f8a05f73a34e969cb5bb32100864e
https://vbn.aau.dk/da/publications/5d26d34b-f497-4f1f-8be7-8a0282f08173
https://vbn.aau.dk/da/publications/5d26d34b-f497-4f1f-8be7-8a0282f08173
Autor:
Christina, Demuth, Morten Nørgaard, Andersen, Kristine Raaby, Jakobsen, Anne Tranberg, Madsen, Boe Sandahl, Sørensen
Publikováno v:
Oncotarget
Introduction Cancer cells can achieve immune evasion by expressing the programmed death receptor 1 ligand (PD-L1) on the cell surface. Blockade of the receptor (PD-1) can avert this evasion. Here we aim at investigating PD-L1 expression in erlotinib-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39e11163fb47e22a32232533b297aa38
https://pubmed.ncbi.nlm.nih.gov/28978110
https://pubmed.ncbi.nlm.nih.gov/28978110
Autor:
Christina Demuth, Morten Nørgaard Andersen, Anne Tranberg Madsen, Kristine Raaby Jakobsen, Peter Meldgaard, Boe Sandahl Sørensen
Publikováno v:
Demuth, C, Andersen, M N, Tranberg Madsen, A, Jakobsen, K R, Meldgaard, P & Sørensen, B S 2015, ' PD-L1 expression is induced by MET in an erlotinib-resistant cell line with MET amplification ', 16th World Conference on Lung Cancer, Denver, Colorado, United States, 06/09/2015-09/09/2015 . < http://library.iaslc.org/virtual-library-search?product_id=1&author=demuth&category= >
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4cca0018ca009ef88d2d3ea56860f174
https://pure.au.dk/portal/da/publications/pdl1-expression-is-induced-by-met-in-an-erlotinibresistant-cell-line-with-met-amplification(f72fb786-e088-4f62-8884-689705f15eca).html
https://pure.au.dk/portal/da/publications/pdl1-expression-is-induced-by-met-in-an-erlotinibresistant-cell-line-with-met-amplification(f72fb786-e088-4f62-8884-689705f15eca).html
Autor:
Christina Demuth, Kristine Raaby Jakobsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sørensen
Publikováno v:
Demuth, C, Jakobsen, K R, Meldgaard, P, Nielsen, A L & Sørensen, B S 2015, ' EGFR and HER3 are important in the interaction between lung cancer cells and fibroblasts ', AACR annual meeting 2015, Philadelphia, PA, United States, 18/04/2015-22/04/2015 . < http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=16383880-72fc-431d-ac37-f52c0626fde5&cKey=e4bcef8f-bb11-4a29-beb4-1c25312b813e&mKey=%7b19573A54-AE8F-4E00-9C23-BD6D62268424%7d >
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1309f97d55ca64c6ebc970c58d084de3
https://pure.au.dk/portal/da/publications/egfr-and-her3-are-important-in-the-interaction-between-lung-cancer-cells-and-fibroblasts(98eaf845-a650-4f61-acf2-ab30fa342b44).html
https://pure.au.dk/portal/da/publications/egfr-and-her3-are-important-in-the-interaction-between-lung-cancer-cells-and-fibroblasts(98eaf845-a650-4f61-acf2-ab30fa342b44).html
Autor:
Kristine Raaby Jakobsen, Birgitte Sandfeld-Paulsen, Rikke Bæk, Kim Varming, Boe Sandahl Sørensen, Malene Jørgensen
Publikováno v:
Jakobsen, K R, Paulsen, B S, Bæk, R, Varming, K, Sørensen, B S & Jørgensen, M 2015, ' Exosomal proteins as diagnostic biomarkers in advanced lung adenocarcinoma ', Journal of Extracellular Vesicles, vol. 4, no. Suppl., P-XVII-5, pp. 165-166 . https://doi.org/10.3402/jev.v4.27783
Aarhus University
Jakobsen, K R, Paulsen, B S, Bæk, R, Varming, K, Sørensen, B S & Jørgensen, M 2015, ' Exosomal proteins as diagnostic biomarkers in advanced lung adenocarcinoma ', the Fourth International Meeting of ISEV, Washington DC, United States, 22/04/2015-26/04/2015 . < http://www.journalofextracellularvesicles.net/index.php/jev/article/view/27783#Scientific%20Program%20ISEV%202015%20meeting%20Saturday%20April%2025%2C%202015%3Cbr%3EOral%20Presentations >
Aarhus University
Jakobsen, K R, Paulsen, B S, Bæk, R, Varming, K, Sørensen, B S & Jørgensen, M 2015, ' Exosomal proteins as diagnostic biomarkers in advanced lung adenocarcinoma ', the Fourth International Meeting of ISEV, Washington DC, United States, 22/04/2015-26/04/2015 . < http://www.journalofextracellularvesicles.net/index.php/jev/article/view/27783#Scientific%20Program%20ISEV%202015%20meeting%20Saturday%20April%2025%2C%202015%3Cbr%3EOral%20Presentations >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::13c966b32a359c56e11ce9433bb484b7
https://vbn.aau.dk/da/publications/c4435080-8a8c-4883-a4fc-521a136b2b17
https://vbn.aau.dk/da/publications/c4435080-8a8c-4883-a4fc-521a136b2b17
Publikováno v:
Østergaard, T, Sørensen, B S, Sørensen, S & Kjems, J, Composition useful as a medicament for treating cancer and/or neuropsychiatric disorders, comprises a binding member capable of binding to a human epidermal growth factor (EGF) receptor 4 (HER4) polypeptide and/or a HER4 RNA, Patentnummer WO2011107100-A1 .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4b1fc593a7e169d869e4af298dbdb311
https://pure.au.dk/portal/da/publications/composition-useful-as-a-medicament-for-treating-cancer-andor-neuropsychiatric-disorders-comprises-a-binding-member-capable-of-binding-to-a-human-epidermal-growth-factor-egf-receptor-4-her4-polypeptide-andor-a-her4-rna(16d5d877-0109-40a1-819e-b2075d1f5a02).html
https://pure.au.dk/portal/da/publications/composition-useful-as-a-medicament-for-treating-cancer-andor-neuropsychiatric-disorders-comprises-a-binding-member-capable-of-binding-to-a-human-epidermal-growth-factor-egf-receptor-4-her4-polypeptide-andor-a-her4-rna(16d5d877-0109-40a1-819e-b2075d1f5a02).html
Autor:
Mathias Munk Sørensen, Ashfaque Ahmed Memon, Thomas Thykjær Andersen, Ebba Nexo, Boe Sandahl Sørensen
Publikováno v:
Sørensen, M M, Memon, A A, Andersen, T T, Nexø, E & Sørensen, B S 2008, ' Expression of the HER4 isoform CYT2 correlates to improved survival in bladder cancer patients lacking Estrogen receptor alpha ', A P M I S Supplementum, no. 5, pp. 435-435 .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cfa23a26c2619f5b31826b5c6429d288
https://pure.au.dk/portal/da/publications/expression-of-the-her4-isoform-cyt2-correlates-to-improved-survival-in-bladder-cancer-patients-lacking-estrogen-receptor-alpha(15245730-0325-11de-a987-000ea68e967b).html
https://pure.au.dk/portal/da/publications/expression-of-the-her4-isoform-cyt2-correlates-to-improved-survival-in-bladder-cancer-patients-lacking-estrogen-receptor-alpha(15245730-0325-11de-a987-000ea68e967b).html